We are live on ! Find out more
CIC

Cornercap Investment Counsel Portfolio holdings

AUM $203M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
+10.87%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$578M
AUM Growth
+$47.7M
Cap. Flow
+$2.02M
Cap. Flow %
0.35%
Top 10 Hldgs %
8.73%
Holding
665
New
115
Increased
180
Reduced
145
Closed
106

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$2.1M
2
ELV icon
Elevance Health
ELV
+$2.08M
3
FOXA icon
Fox Class A
FOXA
+$1.97M
4
TMUS icon
T-Mobile US
TMUS
+$1.96M
5
WM icon
Waste Management
WM
+$1.87M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$4.29M
2
SYF icon
Synchrony
SYF
+$3.13M
3
SSNC icon
SS&C Technologies
SSNC
+$2.87M
4
AEP icon
American Electric Power
AEP
+$2.59M
5
MU icon
Micron Technology
MU
+$2.21M

Sector Composition

Rank Sector Weight
1 Financials 20.35%
2 Healthcare 13.96%
3 Technology 13.54%
4 Industrials 12.88%
5 Energy 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIAN
476
DELISTED
LianBio American Depositary Shares
LIAN
$272K 0.05%
165,718
+83,888
+103% +$131K
SRRK icon
477
Scholar Rock
SRRK
$6.34B
$271K 0.05%
29,906
BCAB icon
478
BioAtla
BCAB
$5.81M
$269K 0.05%
651
ENTA icon
479
Enanta Pharmaceuticals
ENTA
$393M
$267K 0.05%
+5,742
New +$262K
GRTS
480
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$266K 0.05%
77,046
LRCX icon
481
Lam Research
LRCX
$390B
$263K 0.05%
6,260
VIR icon
482
Vir Biotechnology
VIR
$1.51B
$263K 0.05%
10,378
EQRX
483
DELISTED
EQRx, Inc. Common Stock
EQRX
$260K 0.05%
+105,598
New +$416K
DEI icon
484
Douglas Emmett
DEI
$1.92B
$256K 0.04%
16,319
FULC icon
485
Fulcrum Therapeutics
FULC
$282M
$254K 0.04%
+34,886
New +$228K
FHN icon
486
First Horizon
FHN
$12B
$251K 0.04%
10,235
MRSN
487
DELISTED
Mersana Therapeutics
MRSN
$250K 0.04%
1,705
TPB icon
488
Turning Point Brands
TPB
$1.77B
$248K 0.04%
11,455
-86
-0.7% -$1.83K
LLY icon
489
Eli Lilly
LLY
$1.08T
$247K 0.04%
676
-93
-12% -$33K
SBUX icon
490
Starbucks
SBUX
$122B
$245K 0.04%
2,471
-256
-9% -$24.2K
SYF icon
491
Synchrony
SYF
$25.5B
$244K 0.04%
7,439
-91,473
-92% -$3.13M
IOVA icon
492
Iovance Biotherapeutics
IOVA
$2.94B
$241K 0.04%
37,683
+19,925
+112% +$156K
SSNC icon
493
SS&C Technologies
SSNC
$18.7B
$239K 0.04%
4,590
-56,725
-93% -$2.87M
DHI icon
494
D.R. Horton
DHI
$42.2B
$238K 0.04%
+2,667
New +$214K
COST icon
495
Costco
COST
$419B
$237K 0.04%
520
CTMX icon
496
CytomX Therapeutics
CTMX
$752M
$237K 0.04%
148,354
ERAS icon
497
Erasca
ERAS
$6.36B
$237K 0.04%
+55,066
New +$373K
EMN icon
498
Eastman Chemical
EMN
$8.55B
$237K 0.04%
2,914
-85
-3% -$6.85K
CRBU icon
499
Caribou Biosciences
CRBU
$168M
$236K 0.04%
+37,625
New +$335K
YMAB
500
DELISTED
Y-mAbs Therapeutics
YMAB
$235K 0.04%
+48,233
New +$350K

Similar funds

Cornercap Investment Counsel's Q4 2022 Portfolio in Review

As of Q4 2022, Cornercap Investment Counsel held 665 positions worth $578M, up 9% from $530M the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Cornercap Investment Counsel's Q4 2022 filing shows 115 new, 180 increased, 145 reduced and 106 closed positions. Its largest new stake was PayPal: 26,281 shares worth $1.87M. The largest sale was Oracle, an estimated $4.29M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

  • Cornercap Investment Counsel's largest Q4 2022 buy was PayPal: 26,281 shares worth $1.87M.
  • Cornercap Investment Counsel added most to ExxonMobil in Q4 2022, an estimated $1.36M increase.
  • Cornercap Investment Counsel's biggest Q4 2022 reduction was Oracle, cutting an estimated $4.29M.
  • Cornercap Investment Counsel fully exited American Electric Power in Q4 2022, selling an estimated $2.59M.
  • Cornercap Investment Counsel's ten largest holdings make up 8.7% of its $578M portfolio in Q4 2022.
  • Cornercap Investment Counsel opened 115 new positions and closed 106 in Q4 2022.
  • Cornercap Investment Counsel's portfolio value rose 9% quarter-over-quarter to $578M.

Based on Cornercap Investment Counsel's 13F filing for Q4 2022, filed 13 Feb 2023.